“…The importance of the inhibitory, plasticity-regulating Nogo-like signaling system in gray matter during development and in adulthood has been revealed by studying the effects of perturbations such as blocking, decreasing, or increasing the Nogo-NgR signaling pathway, causing increased and decreased plasticity, respectively (McGee et al, 2005; Park et al, 2006a,b; Lee et al, 2008; Karlén et al, 2009; Wills et al, 2012; Akbik et al, 2013; Tews et al, 2013; Petrasek et al, 2014a; Iobbi et al, 2016; Karlsson et al, 2016; Kellner et al, 2016; Stephany et al, 2016a,b; Zagrebelsky et al, 2017). Increased levels of Nogo-A have been reported in schizophrenia (Novak et al, 2002), multiple sclerosis (Satoh et al, 2005), temporal lobe epilepsy (Bandtlow et al, 2004) and Alzheimer’s disease (Gil et al, 2006).…”